- Home
- ORKA vs CBNK Comparison
ORKA vs CBNK Comparison
Compare ORKA & CBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- CBNK
- Stock Information
- Founded
- ORKA 2004
- CBNK 1974
- Country
- ORKA United States
- CBNK United States
- Employees
- ORKA N/A
- CBNK N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CBNK Major Banks
- Sector
- ORKA Health Care
- CBNK Finance
- Exchange
- ORKA Nasdaq
- CBNK Nasdaq
- Market Cap
- ORKA 580.3M
- CBNK 542.0M
- IPO Year
- ORKA N/A
- CBNK 2018
- Fundamental
- Price
- ORKA $15.44
- CBNK $34.48
- Analyst Decision
- ORKA Strong Buy
- CBNK Hold
- Analyst Count
- ORKA 9
- CBNK 1
- Target Price
- ORKA $40.38
- CBNK $35.00
- AVG Volume (30 Days)
- ORKA 142.1K
- CBNK 66.3K
- Earning Date
- ORKA 08-11-2025
- CBNK 07-28-2025
- Dividend Yield
- ORKA N/A
- CBNK 1.41%
- EPS Growth
- ORKA N/A
- CBNK 11.33
- EPS
- ORKA N/A
- CBNK 2.69
- Revenue
- ORKA N/A
- CBNK $205,155,000.00
- Revenue This Year
- ORKA N/A
- CBNK $47.27
- Revenue Next Year
- ORKA N/A
- CBNK $7.48
- P/E Ratio
- ORKA N/A
- CBNK $12.71
- Revenue Growth
- ORKA N/A
- CBNK 30.26
- 52 Week Low
- ORKA $5.49
- CBNK $24.10
- 52 Week High
- ORKA $52.32
- CBNK $36.40
- Technical
- Relative Strength Index (RSI)
- ORKA 59.14
- CBNK 64.30
- Support Level
- ORKA $14.10
- CBNK $31.58
- Resistance Level
- ORKA $15.76
- CBNK $32.80
- Average True Range (ATR)
- ORKA 1.12
- CBNK 0.87
- MACD
- ORKA 0.04
- CBNK 0.23
- Stochastic Oscillator
- ORKA 83.71
- CBNK 100.00
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About CBNK Capital Bancorp Inc.
Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage, and also operates in five business segments: commercial banking; mortgage banking; credit cards; government loan servicing; and corporate activities.